Diasome Pharmaceuticals, run by a father-son team in Ohio, is developing a nanotech compound that would make insulin work better in the liver.
From https://www.healthline.com/diabetesmine/diasome-liver-insulin-therapy
From https://heidifrost.blogspot.com/2019/04/diasome-father-son-developing-nanotech.html
from
https://heidifrost0.wordpress.com/2019/04/30/diasome-father-son-developing-nanotech-to-improve-insulin-effectiveness/
No comments:
Post a Comment